- Tytuł:
- The outlook for alemtuzumab in multiple sclerosis.
- Autorzy:
- Źródło:
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2013 Jun; Vol. 27 (3), pp. 181-9.
- Typ publikacji:
- Journal Article; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Antibodies, Monoclonal, Humanized /*therapeutic use
Immunosuppressive Agents/*therapeutic use
Multiple Sclerosis/*drug therapy
Alemtuzumab ;Antibodies, Monoclonal, Humanized /administration & dosage ;Antibodies, Monoclonal, Humanized /adverse effects ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Lymphopenia/chemically induced ; Multiple Sclerosis/immunology ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Randomized Controlled Trials as Topic ; T-Lymphocyte Subsets/drug effects ; T-Lymphocyte Subsets/immunology
Czasopismo naukowe